- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | Biogen CEO hails quartet of new launches as multiple sclerosis competition weighs on 2025 guidance | ||
| 12.02. | Amid takeover talk, SpringWorks scores FDA nod for rare genetic disease treatment Gomekli | ||
| 11.02. | Lilly encourages women to 'take health into their own hands' with new breast cancer awareness ad | ||
| 11.02. | FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls | ||
| 11.02. | Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowly | ||
| 11.02. | Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx | ||
| 11.02. | British biotech Oxford Cannabinoid Technologies rebrands as Octavian Therapeutics, seeking to establish new empire after setbacks in 2024 | ||
| 11.02. | Antibody supplier Bio X Cell beefs up international presence with new Beijing distribution center | ||
| 11.02. | Bayer brings heart health message to Super Bowl, warning millennials to open their eyes to risks | ||
| 10.02. | Incyte's JAK cream Opzelura picks up steam as company works to revive Jakafi XR dreams | ||
| 10.02. | Merck KGaA sets its sights on acquisition of Ogsiveo-maker SpringWorks: Reuters | ||
| 10.02. | Axsome shares jump as settlement will keep Teva's Auvelity generic off the market until 2038 | ||
| 10.02. | Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment push in the country | ||
| 10.02. | Bristol Myers angles Breyanzi for another blood cancer as it works to close Gilead's CAR-T lead | ||
| 07.02. | How ViiV Healthcare plans to 'show up even better' in the fight against HIV in Black communities | ||
| 07.02. | Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma | ||
| 07.02. | J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing | ||
| 07.02. | Roche details Gazyva's positive data en route to key lupus nephritis expansion | ||
| 06.02. | Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration | ||
| 06.02. | Invivyd tweaks COVID prophylactic playbook, teaming with NFL coach Harbaugh for awareness drive | ||
| 06.02. | Eli Lilly logs massive Q4 revenue jump-but it's not just thanks to Mounjaro and Zepbound | ||
| 06.02. | Nephrologists already aboard GLP-1 bandwagon, providing launchpad for Ozempic in CKD: Spherix | ||
| 06.02. | AstraZeneca warns of potential tax fines amid China sales slowdown, illegal drug importation probe | ||
| 06.02. | Bristol Myers Squibb, amid restructuring, unveils plan to cut another $2B in costs | ||
| 06.02. | After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
